These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 35710136)

  • 1. New Technologies Bloom Together for Bettering Cancer Drug Conjugates.
    Jin Y; Edalatian Zakeri S; Bahal R; Wiemer AJ
    Pharmacol Rev; 2022 Jul; 74(3):680-711. PubMed ID: 35710136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural-source payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions.
    Li C; Shi K; Zhao S; Liu J; Zhai Q; Hou X; Xu J; Wang X; Liu J; Wu X; Fan W
    Pharmacol Res; 2024 Sep; 207():107341. PubMed ID: 39134188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Design of next generation antibody drug conjugates].
    Zhu GD; Fu YX
    Yao Xue Xue Bao; 2013 Jul; 48(7):1053-70. PubMed ID: 24133971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-drug conjugates for targeted cancer therapy: Recent advances in potential payloads.
    Xi M; Zhu J; Zhang F; Shen H; Chen J; Xiao Z; Huangfu Y; Wu C; Sun H; Xia G
    Eur J Med Chem; 2024 Oct; 276():116709. PubMed ID: 39068862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
    Yamada K; Ito Y
    Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential.
    Ceci C; Lacal PM; Graziani G
    Pharmacol Ther; 2022 Aug; 236():108106. PubMed ID: 34990642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive review on the elaboration of payloads derived from natural products for antibody-drug conjugates.
    Lu N; Wu J; Tian M; Zhang S; Li Z; Shi L
    Eur J Med Chem; 2024 Mar; 268():116233. PubMed ID: 38408390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-drug conjugates: using monoclonal antibodies for delivery of cytotoxic payloads to cancer cells.
    Goldmacher VS; Kovtun YV
    Ther Deliv; 2011 Mar; 2(3):397-416. PubMed ID: 22834009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Recent Developments of ADCs with the Tubulysins as the Payloads.
    Xiangrong X; Yao L; Yao A
    Mini Rev Med Chem; 2023; 23(18):1797-1805. PubMed ID: 36825713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Tolerability of Antibody-Drug Conjugates in Cancer.
    Wolska-Washer A; Robak T
    Drug Saf; 2019 Feb; 42(2):295-314. PubMed ID: 30649747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-drug conjugates: an emerging modality for the treatment of cancer.
    Leal M; Sapra P; Hurvitz SA; Senter P; Wahl A; Schutten M; Shah DK; Haddish-Berhane N; Kabbarah O
    Ann N Y Acad Sci; 2014 Aug; 1321():41-54. PubMed ID: 25123209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-drug conjugates: Principles and opportunities.
    Phuna ZX; Kumar PA; Haroun E; Dutta D; Lim SH
    Life Sci; 2024 Jun; 347():122676. PubMed ID: 38688384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads.
    Tonon G; Rizzolio F; Visentin F; Scattolin T
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-Drug Conjugate: A Novel Drug Design Approach.
    Ma L; Wang C; He Z; Cheng B; Zheng L; Huang K
    Curr Med Chem; 2017; 24(31):3373-3396. PubMed ID: 28393694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antibody-drug conjugates based on DXd-ADC technology.
    Chen R; Ren Z; Bai L; Hu X; Chen Y; Ye Q; Hu Y; Shi J
    Bioorg Chem; 2024 Oct; 151():107697. PubMed ID: 39121594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-drug Conjugate Targets, Drugs, and Linkers.
    Teicher BA; Morris J
    Curr Cancer Drug Targets; 2022; 22(6):463-529. PubMed ID: 35209819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly of pH-Responsive Antibody-Drug-Inspired Conjugates.
    Raabe M; Heck AJ; Führer S; Schauenburg D; Pieszka M; Wang T; Zegota MM; Nuhn L; Ng DYW; Kuan SL; Weil T
    Macromol Biosci; 2022 Feb; 22(2):e2100299. PubMed ID: 34791790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel linkers and connections for antibody-drug conjugates to treat cancer and infectious disease.
    Pillow TH
    Pharm Pat Anal; 2017 Jan; 6(1):25-33. PubMed ID: 28155578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-drug conjugates: What drives their progress?
    Pander G; Uhl P; Kühl N; Haberkorn U; Anderl J; Mier W
    Drug Discov Today; 2022 Oct; 27(10):103311. PubMed ID: 35787480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkers Having a Crucial Role in Antibody-Drug Conjugates.
    Lu J; Jiang F; Lu A; Zhang G
    Int J Mol Sci; 2016 Apr; 17(4):561. PubMed ID: 27089329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.